Sinobioway Medicine(SZ:002581) Zheng Quan Zhi Xing·2025-08-29 18:21Core Points - The company, Shandong Weiming Bio-Pharmaceutical Co., Ltd., has proposed a stock option incentive plan for 2025, aiming to enhance corporate governance and align the interests of shareholders, the company, and employees [8][36]. - The plan involves granting a total of 46 million stock options, representing 6.97% of the company's total share capital, with a one-time grant and no reserved rights [2][13]. - The exercise price for the stock options is set at 7.39 RMB per share, with adjustments possible based on corporate actions such as stock dividends or capital increases [5][17]. Summary by Sections Plan Overview - The stock option incentive plan is established in accordance with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1][8]. - The plan is designed to motivate 154 individuals, including directors, senior management, and key technical/business personnel, excluding independent directors [4][11]. Stock Options Details - The total number of stock options granted is 46 million, which does not exceed 10% of the company's total share capital [2][13]. - Each stock option grants the right to purchase one share of the company's A-shares at the specified exercise price [2][13]. Duration and Conditions - The effective period of the incentive plan is up to 44 months from the date of stock option authorization [3][6]. - The plan includes specific conditions under which stock options can be granted and exercised, ensuring compliance with regulatory requirements [19][20]. Performance Assessment - The performance assessment for the stock options is based on company-level and individual-level criteria, with specific growth targets set for revenue and net profit [21][22]. - The company aims for a net profit growth rate of at least 10% for the second exercise period, ensuring that performance metrics are aligned with shareholder interests [21][24]. Adjustments and Accounting - The plan outlines methods for adjusting the number of stock options and exercise prices in response to corporate actions [26][27]. - The company will use the Black-Scholes model to calculate the fair value of the stock options for accounting purposes [29][30].